ABL Bio

298380.KQ

138.04 USD

11.19

+8.82%

Overview

Last close

138.04 usd

Market cap

6.70B usd

52 week high

138.04 usd

52 week low

15.54 usd

Target price

84.66 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

110.5696

Price/Book Value

56.3145

Enterprise Value

6.92B usd

EV/Revenue

115.1173

EV/EBITDA

-32.1061

Key financials

Revenue TTM

60.14M usd

Gross Profit TTM

60.10M usd

EBITDA TTM

-18.19M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

167.77M usd

Net debt

N/A usd

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.